CELLULAR DAMAGE AND RECOVERY OF THE EARLY DEVELOPING MOUSE EYE FOLLOWING LOW DOSE IRRADIATION. II: X-RAYS ON DAY 9 OF GESTATIONBALLA I; MICHEL C; FRITZ NIGGLI H et al.1983; EXPERIENTIA; ISSN 0014-4754; CHE; DA. 1983; VOL. 39; NO 1; PP. 95-96; BIBL. 10 REF.Article

Resolution of risperidone-induced hyperprolactinemia with substitution of quetiapineARUN RAJ KUNWAR; MEGNA, James L.The Annals of pharmacotherapy. 2003, Vol 37, Num 2, pp 206-208, issn 1060-0280, 3 p.Article

Clinical disorders in patients with hyperprolactinaemia. Experience with 59 patientsGRUNSTEIN, H; CLIFTON-BLIGH, P; COLAGIURI, S et al.Medical journal of Australia. 1984, Vol 140, Num 2, pp 64-69, issn 0025-729XArticle

ELIMINATION KINETICS OF IOPAMIDOL, A NEW WATER SOLUBLE NONIONIC RADIOGRAPHIC CONTRAST MEDIUM, ANALYZED BY RADIOACTIVATIONMURATORE O; SAITTA S; MALLARINI G et al.1983; EXPERIENTIA; ISSN 0014-4754; CHE; DA. 1983; VOL. 39; NO 1; PP. 119-121; BIBL. 23 REF.Article

Hyperprolactinaemia in Zimbabwean womenKASULE, J; CHIMBIRA, T. H. K.Central african journal of medicine. 1987, Vol 33, Num 7, pp 173-178, issn 0008-9176Article

CHANGES IN NALORPHINE-INDUCED HYPERPROLACTINAEMIA AFTER BROMOCRIPTINE OR SULPIRIDE ADMINISTRATIONBARRECA T; MAGNANI G; SANNIA A et al.1982; EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 4; PP. 375-376; BIBL. 18 REF.Article

TREATMENT OF HYPERPROLACTINAEMIA WITH METERGOLINE FOR PERIODS UP TO 5 YEARS: CLINICAL AND BIOLOGICAL TOLERABILITYFALSETTI L; VOLTOLINI AM; SCHIMBERNI M et al.1983; CURRENT MEDICAL RESEARCH AND OPINION; ISSN 0300-7995; GBR; DA. 1983; VOL. 8; NO 5; PP. 327-332; BIBL. 14 REF.Article

LA PROLACTINE. PHYSIOLOGIE ET PATHOLOGIETHOMAS M; GARDETTE J.1980; COEUR MED. INTERNE; FRA; DA. 1980; VOL. 19; NO 2; PP. 207-217; ABS. ENG; BIBL. 60 REF.Article

HYPERPROLACTINEMIE DES ANTI-EMETIQUES: COMPARAISON DE QUATRE PRODUITSSEGRESTAA JM; GUERIS J; JULIEN D et al.1979; THERAPIE; FRA; DA. 1979; VOL. 34; NO 4; PP. 437-443; ABS. ENG; BIBL. 13 REF.Article

MENSCHLICHES PROLAKTIN = LA PROLACTINE HUMAINEVONWERDER K; RJOSK HK.1979; KLIN. WSCHR.; DEU; DA. 1979; VOL. 57; NO 1; PP. 1-12; ABS. ENG; BIBL. 143 REF.Article

ENDOCRINE PROFILE AND THERAPEUTIC EMPLOYMENT OF A NEW PROLACTIN-LOWERING DRUG, METERGOLINEFERRARI C; RESCHINI E; PERACCHI M et al.1980; GYNECOL. OBSTETR. INVEST.; CHE; DA. 1980; VOL. 11; NO 1; PP. 1-16; BIBL. 95 REF.Article

SELLES TURCIQUES VIDES ET SYNDROMES ENDOCRINIENSFOSSATI P; CLARISSE J; DECOULX M et al.1979; REV. PRATICIEN; FRA; DA. 1979; VOL. 29; NO 11; PP. 937-947; (7 P.); ABS. ENG; BIBL. 12 REF.Article

HYPOGONADISME MASCULIN.RUEDI B.1978; REV. MED. SUISSE ROMANDE; SUISSE; DA. 1978; VOL. 98; NO 5; PP. 223-235 (6P.); BIBL. 19 REF.Article

Increased arginine-vasopressin response to hypertonic stimulation and upright posture in idiopathic hyperprolactinemiaCOIRO, Vittorio; VOLPI, Riccardo; CATALDO, Simona et al.Regulatory peptides. 2011, Vol 167, Num 2-3, pp 167-169, issn 0167-0115, 3 p.Article

The dopamine receptor D₂ genotype is associated with hyperprolactinemiaHANSEN, Keith A; YUEYI ZHANG; COLVER, Robert et al.Fertility and sterility. 2005, Vol 84, Num 3, pp 711-718, issn 0015-0282, 8 p.Conference Paper

Fructus agni casti and bromocriptine for treatment of hyperprolactinemia and mastalgiaKILICDAG, E. B; TARIM, E; BAGIS, T et al.International journal of gynaecology and obstetrics. 2004, Vol 85, Num 3, pp 292-293, issn 0020-7292, 2 p.Article

Coexistent primary empty sella syndrome and hyperprolactinemia: report of 11 casesGHARIB, H; FREY, H. M; LAWS, E. R. JR et al.Archives of internal medicine (1960). 1983, Vol 143, Num 7, pp 1383-1386, issn 0003-9926Article

A retrospective study of idiopathic hyperprolactinemiasFALSETTI, L; ZANAGNOLO, V; GASTALDI, A et al.Current therapeutic research. 1988, Vol 43, Num 6, pp 1063-1072, issn 0011-393XArticle

Quand et comment traiter une hyperprolactinémie ? = When and how should hyperprolactinemia be treated?BACHELOT, Anne; COURTILLOT, Carine; TOURAINE, Philippe et al.La Presse médicale (1983). 2005, Vol 34, Num 10, pp 731-737, issn 0755-4982, 7 p.Article

Prise en charge d'une hyperprolactinémie en 2003MAITERI, D.Louvain médical. 2003, Vol 122, Num 6, pp S232-S240, issn 0024-6956Conference Paper

Effects of hyperprolactinaemia on core temperature of the ratDRAGO, F; AMIR, S.Brain research bulletin. 1984, Vol 12, Num 4, pp 355-358, issn 0361-9230Article

Hyperprolactinaemia: two casesGORMAN, R. F.Medical journal of Australia. 1984, Vol 140, Num 12, pp 745-746, issn 0025-729XArticle

Hyperprolactinemia: clinical implicationsARCHER, D. F.Progress in Gynecology. 1983, Vol 7, pp 81-100, issn 0079-6298Article

EFFECTIVENESS OF PERGOLIDE MESYLATE IN LONG TERM TREATMENT OF HYPERPROLACTINAEMIAFRANKS S; HORROCKS PM; LYNCH SS et al.1983; BRITISH MEDICAL JOURNAL; ISSN 0007-1447; GBR; DA. 1983; VOL. 286; NO 6372; PP. 1177-1179; BIBL. 10 REF.Article

MAMMOSOMATOTROPH CELL ADENOMA OF THE HUMAN PITUITARY: A MORPHOLOGIC ENTITYHORVATH E; KOVACS K; KILLINGER DW et al.1983; VIRCHOWS ARCHIV. A. PATHOLOGICAL ANATOMY AND HISTOLOGY; ISSN 0340-1227; DEU; DA. 1983; VOL. 398; NO 3; PP. 277-289; BIBL. 11 REF.Article